Abstract:Objective To explore the role of P-glycoprotein(P-gp)170 in steroid resistant nephrotic syndrome(NS) and the mechanism involved. Methods Twenty-four children with NS without any glucocorticoid(GC) treatment before GC administration were divided into 2 groups:steroid-sensitive NS(SSNS) group and steroid-responsive NS(SRNS) group according to the results of follow-up,with 10 healthy children serving as healthy control group.Each subject was treated with dexamethasone(Dex) and cultivated,and Western blot assay was adopted to test P-gp170 expression in membrane of peripheral blood mononuclear cells(PBMC) at different time points,namely at 0 h,12 h,24 h and 36 h,and at the same time,samples without Dex treatment serving as blank control. Results 1.No change was found of P-gp170 expressions in SSNS blank at different time points,thus no significant difference was found among them according to statistics(P>0.05);P-gp170 expressions in SSNS blank control at different time points were all higher compared with healthy blank control group,thus significant differences were found among them according to statistics(P<0.05);P-gp170 expression in Dex-treated SSNS decreased by and by,with a significant difference among different time points statistically(P<0.05);P-gp170 expression at different time points were all higher in Dex-treated SSNS compared with Dex-treated healthy controls,thus a significant difference was found among them according to statistics(P<0.05);P-gp170 expression in Dex-treated SSNS were all higher than those of SSNS blank controls,thus a significant diffe-rence was found at each time point statistically(P<0.05).2.No change was found of P-gp170 expression in SRNS at different time points,thus no significant difference was found among them according to statistics(P>0.05);and there was difference of P-gp170 expression compared with healthy blank controls statistically(P<0.05);No change was found of P-gp170 expression in Dex-treated SRNS at different times,thus no significant difference was found among them according to statistics(P>0.05);and statistically there was difference of P-gp170 expression level compared with SRNS(P<0.05);P-gp170 expression at different time points were all lower compared with SRNS blank control,thus a significant difference was found among them according to statistics(P_a<0.05),and P-gp170 expression in Dex-treated SRNS of different time points were all lower,so significant differences were found among groups according to statistics(P_a<0.05),but no change of P-gp170 expression in Dex-treated SRNS was found at different time points compared with SRNS blank control,thus no significant difference was found among them according to statistics(P>0.05). Conclusions 1.Expression of P-gp170 is found both in healthy controls and children with NS with the later being higher than the former.2.Mechanism of some children with SRNS may attribute to up-regulation of P-gp170 primarily.3.GC administration may lead to higher expression of P-gp170 in cell membrane,and a large amount of GC administration during a long period of time clinically may result in GC resistance by way of up-regulating the expression of P-gp170.

The Expression of the Costimulatory Molecule CD28 and Its Clinical Significance in Patients with Primary Nephrotic Syndrome

Elevated Levels of Immunoglobulin E May Indicate Steroid Resistance or Relapse in Adult Primary Nephrotic Syndrome, Especially in Minimal Change Nephrotic Syndrome

Lymphocyte Subpopulation, Interleukin-2 and High Affinity Interleukin-2 Receptor Expression in Primary Nephrotic Syndrome

Clinical Significance of Serum Cytokines-level and T Cell Subsets in Children with Primary Nephrotic Syndrome

Changes of Renal Tissue TNF-α,Plasma TNF-α and Urine TNF-α in Patients with Primary Nephrotic Syndrome

Level of Th17 Cell and CD4+ CD25 + Foxp3+ Regulatory T Cell in Peripheral Blood Mononuclear Cells of Primary Nephrotic Syndrome in Children

Clinical Significance of Meassuring Serum Cortisol and T Lymphocyte Subsets in Children with Nephrotic Syndrome

The variation and its clinical significance of Th1/Th2 and CD28 + cells from peripheral blood in patients with chronic glomerulonephritis

The immune cell landscape of peripheral blood mononuclear cells from PNS patients

Clinical and Pathological Manifestations and Prognosis in 51 Children with Refractory Nephrotic Syndrome

Analysis of Peripheral Blood CD8+ Regulatory Lymphocytes from the Patients with Systemic Lupus Erythematosus

Influence and clinical efficacy of Tripterygium glycosides combined with glucocorticoid on regulatory T cells of patients with nephritic syndrome

Abnormality and Clinical Significance of Th9 Cells and IL-9 in the Periph-eral Blood of Patients with Primary Nephrotic Syndrome

Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity

Comparison of the efficacy of steroid-free versus classic steroid-containing regimens in primary membranous nephropathy

Significance of Expression of P-Glycoprotein 170 in Peripheral Blood Mononuclear Cells of Children with Primary Nephrotic Syndrome

Involvement of expanded cytotoxic and proinflammatory CD28null T cells in primary Sjögren's syndrome

Predictability of Urinary CD80 in the Relapse of Primary Nephrotic Syndrome

New Insights Into Treatment Of Nephrotic Syndrome In Children

Expression of CD2AP on Podocytes with Different Pathological Types of Nephrotic Syndrome

A New Role for CD28 in the Survival of Autoreactive T Cells in the Periphery after Chronic Exposure to Autoantigen.